| Kristen Shaw Deitchman, DO | |
|
4924 Campbell Blvd, Suite 200, Nottingham, MD 21236-5908 | |
| (443) 442-2300 | |
| (410) 367-2035 |
| Full Name | Kristen Shaw Deitchman |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 4924 Campbell Blvd, Nottingham, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477849149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | H0081342 (Maryland) | Primary |
| Entity Name | Johns Hopkins Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598868 PECOS PAC ID: 8325943707 Enrollment ID: O20031220000065 |
News Archive
Presidential action to alter current law risks undermining progress made by Congress, the American people, and a cadre of healthcare stakeholders to improve care access, care quality, and care costs for us all as we age, so say experts at the American Geriatrics Society evaluating recent orders by the Trump Administration.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Nonalcoholic fatty liver disease is becoming more and more common. Approximately every third adult in the industrialized countries has a morbidly fatty liver.
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.
› Verified 2 days ago
| Entity Name | Upper Chesapeake Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497801419 PECOS PAC ID: 3173556974 Enrollment ID: O20050913000525 |
News Archive
Presidential action to alter current law risks undermining progress made by Congress, the American people, and a cadre of healthcare stakeholders to improve care access, care quality, and care costs for us all as we age, so say experts at the American Geriatrics Society evaluating recent orders by the Trump Administration.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Nonalcoholic fatty liver disease is becoming more and more common. Approximately every third adult in the industrialized countries has a morbidly fatty liver.
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Shaw Deitchman, DO 4924 Campbell Blvd, Suite 200, Nottingham, MD 21236-5908 Ph: (443) 442-2300 | Kristen Shaw Deitchman, DO 4924 Campbell Blvd, Suite 200, Nottingham, MD 21236-5908 Ph: (443) 442-2300 |
News Archive
Presidential action to alter current law risks undermining progress made by Congress, the American people, and a cadre of healthcare stakeholders to improve care access, care quality, and care costs for us all as we age, so say experts at the American Geriatrics Society evaluating recent orders by the Trump Administration.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
Alexza Pharmaceuticals, Inc. announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.
Nonalcoholic fatty liver disease is becoming more and more common. Approximately every third adult in the industrialized countries has a morbidly fatty liver.
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.
› Verified 2 days ago
Smita N Vazarkar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4924 Campbell Blvd Ste 200, Nottingham, MD 21236 Phone: 443-442-2300 | |
Christina Margaret Brown, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7600 Fax: 410-933-7601 | |
Ethel Mojoko, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4924 Campbell Blvd, #200, Nottingham, MD 21236 Phone: 443-442-2300 | |
Dr. Anthony F Pinto Iii, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4924 Campbell Blvd Ste 200, Nottingham, MD 21236 Phone: 443-442-2300 | |
Dr. Richard Laroy Dietrich, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4920 Campbell Blvd, Kaiser Permanente White Marsh Medical Center, Nottingham, MD 21236 Phone: 410-933-7600 Fax: 410-933-7802 | |
Dr. Judith Rubin Dejarnette, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7600 |